Cargando…
CheckMate-915: does adjuvant CTLA-4 blockade play a role in resected melanoma?
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
AME Publishing Company
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10477634/ https://www.ncbi.nlm.nih.gov/pubmed/37675335 http://dx.doi.org/10.21037/atm-23-754 |
| _version_ | 1785101175431888896 |
|---|---|
| author | Su, David Kluger, Harriet Weiss, Sarah A. |
| author_facet | Su, David Kluger, Harriet Weiss, Sarah A. |
| author_sort | Su, David |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10477634 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | AME Publishing Company |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-104776342023-09-06 CheckMate-915: does adjuvant CTLA-4 blockade play a role in resected melanoma? Su, David Kluger, Harriet Weiss, Sarah A. Ann Transl Med Editorial Commentary AME Publishing Company 2023-03-06 2023-08-30 /pmc/articles/PMC10477634/ /pubmed/37675335 http://dx.doi.org/10.21037/atm-23-754 Text en 2023 Annals of Translational Medicine. All rights reserved. https://creativecommons.org/licenses/by-nc-nd/4.0/Open Access Statement: This is an Open Access article distributed in accordance with the Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International License (CC BY-NC-ND 4.0), which permits the non-commercial replication and distribution of the article with the strict proviso that no changes or edits are made and the original work is properly cited (including links to both the formal publication through the relevant DOI and the license). See: https://creativecommons.org/licenses/by-nc-nd/4.0 (https://creativecommons.org/licenses/by-nc-nd/4.0/) . |
| spellingShingle | Editorial Commentary Su, David Kluger, Harriet Weiss, Sarah A. CheckMate-915: does adjuvant CTLA-4 blockade play a role in resected melanoma? |
| title | CheckMate-915: does adjuvant CTLA-4 blockade play a role in resected melanoma? |
| title_full | CheckMate-915: does adjuvant CTLA-4 blockade play a role in resected melanoma? |
| title_fullStr | CheckMate-915: does adjuvant CTLA-4 blockade play a role in resected melanoma? |
| title_full_unstemmed | CheckMate-915: does adjuvant CTLA-4 blockade play a role in resected melanoma? |
| title_short | CheckMate-915: does adjuvant CTLA-4 blockade play a role in resected melanoma? |
| title_sort | checkmate-915: does adjuvant ctla-4 blockade play a role in resected melanoma? |
| topic | Editorial Commentary |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10477634/ https://www.ncbi.nlm.nih.gov/pubmed/37675335 http://dx.doi.org/10.21037/atm-23-754 |
| work_keys_str_mv | AT sudavid checkmate915doesadjuvantctla4blockadeplayaroleinresectedmelanoma AT klugerharriet checkmate915doesadjuvantctla4blockadeplayaroleinresectedmelanoma AT weisssaraha checkmate915doesadjuvantctla4blockadeplayaroleinresectedmelanoma |